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Indonesia is one of the countries with the second highest 
dengue cases in Southeast Asia in 2004- 2010 (WHO, 2012). 
Examination used in diagnosis of DHF diagnosis is platelet 
count, which is done at Mitra Kemayoran Hospital, if a clot 
occurs when checking platelets using EDTA anti- coagulant. 
The purpose of this study was to determine differences in 
platelet count results using EDTA and Na Citrat 
anticoagulants. This research was conducted at Mitra 
Kemayoran Hospital in April - June 2018. The samples in 
this study were all patients who performed platelet count 
examination at Mitra Kemayoran Hospital in April - June 
2018. The data in this study were carried out by examining 
the platelet count using anticoagulants EDTA and Na Citrat. 
The data in this study were analyzed using Normality Test 
and t-est Test. The results at this time obtained the p-value 
of the examination results of 0.222 from these results can be 
censored if there are no correct results from examining the 
platelet count using EDTA and Na Citrat anticoagulants. 
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1. INTRODUCTION 
Dengue Hemorrhagic Fever (DHF) is 
considerably a new disease or a new variant of 
dengue infection because of its unusual 
hemorrhages and the shock syndrome so-called 
dengue shock syndrome (DSS) which has been 
known for more than a century in Asia are 
largely age dependent, the disease is mild in 
children and more severe in adults. Infants and 
young children with dengue infection have 
syndrome ranging from undifferentiated fever 
to mild febrile illness sometimes with the triad 
of high fever, pain in various parts of the body 
and rash. The disease is known as non-fatal, 
death is rather an exceptional. DHF on the 
contrary, attacks mostly children under age 14 
years and caused significant mortality among 
preschool age children of Southeast Asia and 
the Western Pacific regions where classical 
dengue syndrome is a rare incidence among 
indigenous people (Nimmannitya, 1975). 
DHF is a disease that affects many 
people in the world with a high prevalence of 
events. World Health Organization (WHO) said 
Indonesia is the second highest DHF country in 
Southeast Asia between 2004-2016 (Indonesian 
Public Health Office, 2012). DHF events in 
Mitra Keluarga Kemayoran Hospital in 2017 
were 419 cases with a decrease in platelet 
counts of 419 cases.  
Examination used in the diagnosis of 
dengue fever included platelet counts. This is 
because thrombocytopenia and 
haemoconcentration are constant findings in 
DHF. A drop in platelet count to below 100.000 
per mm
3
 is usually found between the third and 
eight day of illness, often before or 
simultaneous with changes in haematocrit  
An adequate supply of circulating 
platelets is essential to maintain vascular 
integrity and to facilitate thrombus formation at 
sites of vascular injury. The normal platelet 
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count in humans ranges from 150×10
9
/L to 
400×10
9
/L. Thrombocytopenia is usually an 
acquired disorder from the situation where 
platelet count less than 150×10
9
/L, 
Thrombocytosis, defined as a platelet count 
exceeding the upper limit of the normal range 
(>400×10
9
/L), is associated with an increased 
risk of thrombosis. (Daly, 2011).  
The platelet count measures the number 
or concentration of platelets in the blood 
stream. The normal platelet count is between 
150 and 450 billion (or 109) per liter of blood. 
In some cases, the platelets are expressed as the 
number per cubic millimeter or microliter of 
blood, with the normal range being between 
150.000 and 450.000. For sake of simplicity, 
the easiest way to express the normal platelet 
count is 150 to 450 (George & Buchanan, 
2012). 
Platelet count testing uses several 
anticoagulants including heparin, and EDTA 
anticoagulant (Handayani, 2009). 
Anticoagulants are additives that inhibit the 
clotting of blood and/or plasma, thereby 
ensuring that the concentration of the substance 
to be measured is changed as little as possible 
before the analytical process (Guder 2001). 
Anti-coagulation is achieved either by the 
binding of calcium ions (EDTA, citrate and 
fluoride) or by the inhibition of thrombin 
(heparin) (Mohri, et al., 2007). 
Based on preliminary research conducted 
at Mitra Kemayoran Hospital, it is known that 
platelet examination using EDTA 
anticoagulants occurs in clumps which cause 
the results of the examination to be less valid. 
The most ideal examination of platelet counts 
uses Sodium Citrate anticoagulants, Na Citrate 
(Longo, 2010). 
Sodium citrate has been used as an 
anticoagulant to stabilize blood and blood 
products for over 100 years, presumably by 
sequestering Ca
2+
 ions in vitro. Anticoagulation 
of blood without chelation can be achieved by 
inhibition of the contact pathway by corn 
trypsin inhibitor (CTI) (Mann et al., 2007). 
 
2. RESEARCH METHODS 
 The place and time in this study were the 
Kemayoran Mitra Keluarga Hospital in May - 
June 2018. The object of this study was patients 
with Dengue Hemorrhagic Fever (DHF) who 
performed thrombocyte examinations at Mitra 
Keluarga Kemayoran Hospital in May - June 
2018. The population in this study is all 
patients suspected of dengue fever that perform 
thrombocyte examinations at Mitra Kemayoran 
Hospital who conduct examinations in May - 
June 2018. Samples in this study were drawn 
by Total Sampling Technique. The data in this 
study were collected by examining platelet 
counts using EDTA anticoagulants and Na 
citrate. The data in this study were analyzed 
using the T-test with Minitab. 
  
3. RESULTS AND DISCUSSION 
 The data in this study were analyzed using 
the Kolmogorov-Smirnov normality test. The 
results of the normality test on this research 
data are presented in the following Table 1. 
 
Tabel 1. Normality Test Result 
Mean -2140 
StDev 10180 
N 35 
KS 0.125 
P-Value >0.150 
 
Based on table 1 it is known that the 
value of the p value homogeneity test is less 
than 0.15, this means that the data is normally 
distributed so that it can be continued using the 
T-test. The value of the T-test in the study was 
analyzed using MINITAB with results such as 
Table 2 below. 
Table 2. Paired t for Thrombocyte EDTA – 
Thrombocyte Citrate 
 
N Mean 
St. 
Deviation 
SE 
Mean 
Thrombocyte 
- EDTA 
35 
62343 28093 4749 
Thrombocyte 
– Citrate 
35 
 
60203 
 
25403 
 
4294 
Difference 35 2140 10180 1721 
 
Based on table 2 it can be seen if the p 
value is 0.222, with these results it can be seen 
if there is no significant difference in the results 
of the platelet count examination using EDTA 
anti-coagulant and Na Citrate. The statistical 
results showed no significant difference, but 
several study samples had different platelet 
count values, differences in platelet count 
values with the use of anti-coagulant EDTA 
and Na Citrate because the most ideal anti-
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coagulant platelet count used was Na Citrate 
compared to EDTA.  
The most ideal examination of platelet 
counts uses Sodium Citrate anticoagulants, Na 
Citrate and Heparin (Longo, 2010). EDTA 
coagulation can reduce platelet activity to 
aggravate (cluster) with calcium and freeze 
quickly, but EDTA binds potassium and 
platelets cannot move to prevent the occurrence 
of adhesion (Gandasoebrata, 2008). 
The essential roles for calcium ion in 
blood clotting reactions were demonstrated by 
Arthus between 1890 and 1896. Ca
2+
 required 
for blood clotting could be neutralized by the 
addition of Na citrate. The prothrombin time 
(PT) and the activated partial thromboplastin 
timemake use of citrate plasma, a source of 
Ca
2+
 and either tissue thromboplastin or contact 
activation. Typically blood is collected into 
3.2% or 3.8% sodium citrate and plasma is 
prepared by differential centrifugation. 
Reactions are initiated by the addition of Ca
2+
 
solutions sufficient to overcome the citrate. 
Citrate anticoagulation has enabled tests of 
coagulant function and has provided stable 
sources of both blood and plasma for clinical 
use, protein isolation and biochemical studies 
(Mann et al., 2007). 
 
4. CONCLUSIONS AND 
RECOMMENDATIONS 
The conclusion of this study is that there 
is no significant difference between the use of 
anti-coagulant EDTA and Na citrate in the 
examination of platelet counts in DHF patients 
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